Rabenoj DSR

Rabeprazole 40mg (EC) + Domperidone 30mg (SR) capsule is a dual-action gastroprotective formulation used for the effective management of acid reflux, GERD, and delayed gastric emptying.

Rabeprazole acts as a proton pump inhibitor, reducing gastric acid secretion, while Domperidone provides prokinetic action, improving gastric motility and preventing bloating, nausea, and discomfort.

This capsule is commonly prescribed for patients with gastroesophageal reflux disease, dyspepsia, gastritis, and other acid-related gastrointestinal disorders, ensuring symptom relief and improved digestion.

With reliable clinical efficacy, combined mechanism of action, and strong acceptance among physicians, this formulation strengthens a gastroenterology product portfolio and supports consistent therapeutic demand.

Common side effects may include headache, dizziness, nausea, diarrhea, or mild abdominal discomfort. Rarely, allergic reactions, liver enzyme changes, or cardiac arrhythmias may occur.

Rabenoj DSR Capsule is indicated for the treatment of gastroesophageal reflux disease (GERD), acid peptic disorders, dyspepsia with delayed gastric emptying, and other conditions requiring acid suppression with prokinetic support, as prescribed by a healthcare professional.

For oral use only. Use under strict medical supervision. Take the capsule as prescribed and avoid crushing or chewing. Caution is advised in patients with liver disease, heart conditions, or prolonged use of proton pump inhibitors.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.